سعر السهم
30.71
التغيير اليومي
-0.39 -1.24%
شهريا
-11.74%
سنويا
90.01%
Q2 التوقعات
29.60




أرباح التشغيل تغيير تاريخ
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
MacroGenics USD -12.1M 30.74M 2025-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pfizer USD 4.65B 3.99B 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Takeda JPY 168.82B 479.89B 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09